Monoclonal Mouse anti‑Human MAPK10 / JNK3 Antibody (clone 8A5D11, IHC, WB) LS‑C47194
Monoclonal Mouse anti‑Human MAPK10 / JNK3 Antibody (clone 8A5D11, IHC, WB) LS‑C47194
Antibody:
MAPK10 / JNK3 Mouse anti-Human Monoclonal (8A5D11) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
MAPK10 / JNK3 Mouse anti-Human Monoclonal (8A5D11) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
JNK3 antibody LS-C47194 is an unconjugated mouse monoclonal antibody to human JNK3 (MAPK10). Validated for ELISA, IHC and WB.
Target
Human MAPK10 / JNK3
Synonyms
MAPK10 | C-Jun N-terminal kinase 3 | JNK3 | JNK3A | MAPK 10 | MAP kinase 10 | MAP kinase p49 3F12 | p493F12 | p54B SAPK | SAPK beta | p54bSAPK | SAPK1b | Serk 2 | JNK3 alpha protein kinase | PRKM10
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Affinity purified
Immunogen
Recombinant human MAPK10 / JNK3.
Specificity
Ni-NTA purified truncated recombinant MAPK10 expressed in E. Coli strain BL21 (DE3)
Applications
- IHC
- Western blot (1:500 - 1:1000)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Storage
Short term: -20°C; Long term: -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 2/12/2025